Prolia Cost in 2026: Injection Prices & How to Save
Twice a year you sit down for a five-second injection, and twice a year the bill lands somewhere between $1,700 and $2,500. Nothing about the appointment feels like it should cost that much.
Prolia (denosumab) is one of the most effective osteoporosis treatments available, and also one of the most confusingly priced. Two people can get the identical 60 mg syringe in the same city and pay wildly different amounts, depending on where the shot is given and which part of their coverage pays for it. Meanwhile, a wave of denosumab biosimilars quietly entered the US market in 2025, and most cost pages haven't caught up.
At a glance
- A single Prolia injection runs about $1,735 to $2,476 without insurance in 2026, and it's given every six months
- That works out to roughly $3,500 to $5,000 a year for the drug alone, before any administration fee
- Denosumab biosimilars like Jubbonti and Bildyos launched in the US and are priced meaningfully below brand Prolia
- Cash-pay options through networks like CanAmerica Plus list Prolia at $429.99 per syringe
- Stopping Prolia to save money carries a real rebound fracture risk, so never quit without a replacement plan from your doctor
How much does a Prolia injection cost without insurance?
Estimates vary by source and pharmacy, but they cluster in a narrow, expensive band.
| Source (2026) | Price per 60 mg syringe |
|---|---|
| GoodRx average cash price | $2,476.07 |
| SingleCare average retail | $2,301.20 |
| Drugs.com price guide (January) | $1,931.69 |
| Healthline / Medicare.org figure | $1,786.12 |
| GoodRx lowest listed | $1,735.90 |
Prolia is dosed at 60 mg subcutaneously once every six months. Two doses a year puts the annual drug cost at roughly $3,500 to $5,000 at retail cash prices.
One patient on the Mayo Clinic Connect forums reported $2,300 per injection in January 2026. That number is worth mentioning because it's what someone actually paid, not a list price scraped from a database.
And the drug is only part of the bill.
Why the same injection has two very different prices
This is the part almost no cost page explains, and it's the single biggest reason Prolia quotes vary so much.
Prolia can be billed two completely different ways:
Through the medical benefit (buy-and-bill). Your doctor's office buys the syringe, stores it, injects it, and bills your insurer for both the drug and the administration. Under Medicare this falls to Part B, typically 20% coinsurance on the drug plus a separate fee for giving the shot.
Through the pharmacy benefit. A pharmacy dispenses the syringe, and you or a nurse brings it to the appointment. Under Medicare this is Part D, where your cost depends on your plan's tier and where you are in the year.
Same molecule, same 60 mg, two entirely different price tags. Amgen's own prescriber materials put the average Medicare Part D out-of-pocket cost at $274 every six months, about $46 a month. Under Part B in a hospital outpatient setting, the same injection can cost several times that.
Savings tip: Ask your prescriber's billing staff to quote the cost both ways before you schedule. Ask specifically: "What would this cost through the pharmacy benefit versus buy-and-bill in your office?" The gap is often several hundred dollars, and the office won't volunteer the comparison unless you ask.
Also ask about site of care. The same injection given in a hospital outpatient department frequently costs more than one given in a physician's office or infusion suite, because facility fees get layered on top.
Denosumab biosimilars are here, and they cost less
This is the most useful thing that's happened to Prolia pricing in a decade, and it's still missing from most articles on the topic.
The FDA approved the first denosumab biosimilars, Jubbonti and Wyost (Sandoz), in March 2024. Sandoz launched them in June 2025. Both are designated interchangeable with Prolia and Xgeva respectively, with the same dosage form, route, and every-six-months schedule.
Pricing so far:
| Product | Type | Listed price |
|---|---|---|
| Prolia (Amgen) | Reference biologic | ~$1,931.69 per injection |
| Jubbonti / Wyost (Sandoz) | Biosimilar | $26.74/mg, ~14.5% below Prolia |
| Bildyos (Organon) | Biosimilar | $844.00 per injection |
A 14.5% discount isn't the 80% drop people expect from generics, and that's worth being honest about. Biosimilars are living cells, not chemical copies, so they're expensive to make and the discounts start smaller. But more manufacturers have entered since, and prices have kept drifting down.
The practical part: some Medicare plans have already moved to replace Prolia and Xgeva with interchangeable biosimilars, in several cases without prior authorization or step edits. If your plan made that switch, your cost may have changed without you noticing.
Ask your prescriber whether a denosumab biosimilar is appropriate for you. "Interchangeable" is a specific FDA designation, and for these products it means the clinical evidence supports substitution.
What Prolia costs through cash-pay options
Cash-pay networks work outside the insurance system entirely, which sometimes produces a lower number than any coupon.
Through CanAmerica Plus, Prolia is listed at $429.99 for one 60 mg/mL prefilled syringe, against a comparison price of $1,298.95. Two doses a year comes to about $860 for the medication.
That's the drug only. You'll still need someone to administer it, and you'll still want your prescriber managing your calcium, vitamin D, and bone density monitoring. A cash price on the syringe doesn't replace the clinical care around it.
Cash-pay also isn't automatically the right answer. If you're on Medicare Part D and hitting the $2,000 annual out-of-pocket cap, your covered cost may already be lower than any cash price. Run your own numbers before switching anything.
How Prolia compares to other osteoporosis medications
Cost is one input. Fracture risk, kidney function, dosing convenience, and how long you've already been treated all matter more, and none of that is a decision to make on price alone.
| Medication | How it's given | CanAmerica Plus cash price |
|---|---|---|
| Prolia (denosumab) | Injection every 6 months | $429.99 per syringe |
| Evenity (romosozumab) | 2 injections monthly, 12 months | $859.99 per 2 syringes |
| Fosamax (alendronate) | Oral tablet, weekly | $210.99 per 12 tabs |
| Actonel (risedronate) | Oral tablet, weekly or monthly | Varies by strength |
| Forteo (teriparatide) | Daily injection | Varies by pack |
Oral bisphosphonates like alendronate are dramatically cheaper and remain first-line for many people with osteoporosis. If you were started on Prolia without ever trying a bisphosphonate, that's a fair question to raise at your next visit.
But the reverse is also true. Prolia is often chosen precisely because someone couldn't tolerate oral bisphosphonates, had esophageal problems, or had reduced kidney function that made other options unsuitable. Switching backward to save money can undo the reason you were put on it.
Why stopping Prolia to save money is risky
If you take one thing from this page, make it this one.
Prolia doesn't behave like most drugs when you stop. Bone turnover doesn't simply return to baseline. It rebounds sharply, and bone loss accelerates within six to twelve months of a missed dose, sometimes faster than if you'd never been treated at all.
The consequence is not theoretical. Research on denosumab discontinuation has found that without appropriate follow-on therapy, up to 10% of patients experience multiple vertebral fractures. The risk appears in people who've had as few as two injections.
The European Calcified Tissue Society and multiple clinical groups now recommend bridging therapy, typically a bisphosphonate such as zoledronic acid, started within about six months of the last denosumab dose. Bridging reduces the risk substantially, though studies show some people still lose bone despite it.
Important: Do not delay, skip, or stop a Prolia dose because of cost without telling your prescriber first. If the price has become unmanageable, say so directly. There is a safe way to come off denosumab and an unsafe way, and the difference is a planned transition to another medication.
Delaying a dose by a few weeks while you sort out pharmacy logistics is a different situation than stopping altogether, but both are worth a phone call rather than a guess.
Practical ways to lower what you pay
A short list of things that actually move the number:
- Compare both billing routes. Pharmacy benefit versus buy-and-bill can differ by hundreds of dollars for the same syringe.
- Ask about a biosimilar. Interchangeable denosumab products are available and priced below brand Prolia.
- Check the site of care. Physician office and infusion suite pricing usually beats hospital outpatient.
- Price the drug through a cash-pay network. Sometimes lower than an insured cost, particularly if you're uninsured or in a high-deductible plan.
- Confirm your Part D position. Medicare's $2,000 annual out-of-pocket cap changes the math for a lot of people, especially late in the year.
- Time your doses sensibly. Two doses landing in the same plan year versus split across two can meaningfully change what you pay, and your prescriber may have some flexibility on scheduling.
The bottom line
Prolia costs roughly $1,735 to $2,476 per injection without insurance in 2026, or $3,500 to $5,000 a year. The two levers most people never pull are asking which billing route is cheaper and asking whether an interchangeable denosumab biosimilar is an option.
Check what Prolia and its alternatives cost through CanAmerica Plus, then bring the numbers to your prescriber. And if cost is the reason you're considering stopping, raise it before you miss a dose, because coming off denosumab safely requires a plan.
Frequently asked questions
Is there a generic version of Prolia?
Not in the conventional sense. Prolia is a biologic, so it gets biosimilars rather than generics. Jubbonti, Bildyos, and other interchangeable denosumab biosimilars are now available in the US and cost less than brand Prolia, though the discounts are smaller than typical generic savings.
How much does Prolia cost with Medicare?
It depends entirely on which part covers it. Amgen's prescriber materials cite an average Part D out-of-pocket cost of $274 every six months. Under Part B you'd generally owe 20% coinsurance plus an administration fee. Medicare's $2,000 annual out-of-pocket cap also limits total exposure on covered drugs.
Why is Prolia so expensive?
It's a monoclonal antibody produced in living cell cultures, which is far costlier to manufacture than a chemical tablet. Amgen also held market exclusivity for well over a decade, and meaningful price competition only began arriving with biosimilar launches in 2025.
Can I stop Prolia once my bone density improves?
Not without a transition plan. Stopping denosumab triggers rapid bone loss and raises the risk of multiple vertebral fractures. Most clinicians move patients onto a bisphosphonate within roughly six months of the final dose. This decision belongs with your prescriber.
Does the price include giving the injection?
Usually not. Quoted drug prices cover the syringe alone. Administration is billed separately, and the fee varies by whether you're seen in a physician's office, an infusion suite, or a hospital outpatient department.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.
